Skip to main content

NCT03070886 - NRG-GU002

Official Title
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
Brief Title
NRG-GU002
Protocol ID
NCT03070886
Lead Sponsor
NRG Oncology
Brief Summary

Phase II-III trial of adjuvant radiotherapy and androgen deprivation following radical prostatectomy with or without adjuvant Docetaxel

Eligibility Criteria

An Institutional Review Board responsible for human subjects research at The University of Arizona reviewed this research project and found it to be acceptable, according to applicable state and federal regulations and University policies designed to protect the rights and welfare of participants in research.

Filters
Completed